Cannabinoids
Hearing scheduled on proposed hemp-derived cannabinoid regulation…
19th December 2023 - Alerts | North America, Tennessee, United States |
DEA temporarily schedules six synthetic cannibinoids…
12th December 2023 - Alerts | United States |
HHC-H temporarily classified as Group 2 narcotic…
11th December 2023 - Alerts | Asia, South Korea |
OMMA asks for authority over intoxicating hemp-derived cannabinoids…
11th December 2023 - Alerts | North America, Oklahoma, United States |
Health Canada releases guidance on intoxicating cannabinoids…
7th December 2023 - Alerts | Canada, North America |
Europe’s intoxicating hemp-derived cannabinoid market: analysis of 2023
5th December 2023 - Market reports |
Following our report earlier this year on IHDC online availability in Europe, this report identifies and examines any change in interest for these products from retailers and consumers in the third quarter of the year
22nd Century sells its hemp/cannabis business to cut debt and operating costs
29th November 2023 - News analysis |
US-based 22nd Century will sell its hemp/cannabis subsidiary, GVB Biopharma, to an entity affiliated with current GVB employees and will use the sale proceeds to pay off debt and further deleverage its balance sheet
Cannabinoids from other sources: the promise that keeps failing to deliver
28th November 2023 - News analysis |
Cannabinoids can be found in numerous plants, animals and fungi, and as more are unearthed and their properties tested, our knowledge of potential applications and uses expands
Colombia: CBD and cannabis regulation, November 2023
28th November 2023 - Regulatory reports |
This report provides a detailed analysis of the current regulatory framework in place in Colombia for cannabis, hemp and other cannabinoids including CBD
Extension of Farm Bill coverage to 2024 means good news for the US hemp sector
27th November 2023 - News analysis |
US hemp farmers will be able to continue operating under the 2018 Farm Bill framework until the end of September next year, as stopgap funding was approved and signed into law by president Joe Biden
Is Japan’s medical cannabis bill in parliament a sign of a cultural change?
23rd November 2023 - Blogs |
Japan may very soon ban hexahydrocannabihexol (HHCH) and other synthetic cannabinoid derivatives in the wake of the country’s first medical cannabis regulation bill passing its initial parliamentary scrutiny
FDA issues warning letter over health claims…
22nd November 2023 - Alerts | North America, United States |
CCCB votes to amend rules limiting THC in hemp products…
21st November 2023 - Alerts | New York, United States |
Japan’s first medical cannabis law: ‘historic shift’ or crackdown on illicit use?
17th November 2023 - News analysis |
Japan’s first medical cannabis law may end up only legalising a single pharmaceutical product, while also criminalising recreational cannabis consumption
Israel: CBD and cannabis regulation, November 2023
14th November 2023 - Regulatory reports |
This report provides analysis of the current regulatory framework in place in Israel for cannabis and cannabinoids, including CBD and hemp. It covers everything from cultivation and processing to finished products, extracts and import/export…
Emergency rule approved to regulate hemp-derived cannabinoid products…
13th November 2023 - Alerts | Kentucky, North America, United States |
Canadian cannabis company Organigram gets $90m from BAT to fund expansion
10th November 2023 - News analysis |
A British American Tobacco (BAT) subsidiary is investing a further CAD124.6m (USD90.2m) in its strategic partnership with Canadian licensed cannabis producer Organigram
Hemp producers sue DNR over new regulation…
9th November 2023 - Alerts | Alaska, North America, United States |
Weaker demand for hemp and cannabis products impacts 22nd Century’s revenue
7th November 2023 - News analysis |
22nd Century reported decreased revenues for the third quarter of 2023 and blamed demand challenges in its hemp/cannabis product distribution business, although this still represents the biggest part of its net revenue
Spain: CBD and cannabis regulation, October 2023
30th October 2023 - Regulatory reports |
This report offers detailed analysis of the current regulatory framework in place in Spain for hemp, CBD and other cannabinoids, as well medical and recreational cannabis
Poland’s next coalition government may take a more liberal stance on cannabis
27th October 2023 - News analysis |
A coalition of centre-right, liberal, and left-wing forces is the most likely to form a new government in Poland before the end of the year, following elections held on 15th October
Government accepts advice on delta-9 THC…
24th October 2023 - Alerts | Europe, United Kingdom |
CBD regulatory progress in US Congress grinds to a halt in partisan gridlock
18th October 2023 - News analysis |
Partisan gridlock continues to keep Congress from clarifying the regulatory framework for CBD. Even as the Biden administration moves to reschedule cannabis, Congress punts CBD issues back and forth with the FDA
How could a new government affect cannabinoid policy in the Netherlands?
17th October 2023 - News analysis |
The nearly 18m people of the Netherlands face uncertainty following the collapse of the government this summer. The Cabinet is currently overseeing the nation with a “caretaker” status until the 22nd November general election
Dispensaries sue over IHDC product sales…
16th October 2023 - Alerts | California, North America, United States |
Thailand: CBD and cannabis regulation, October 2023
4th October 2023 - Regulatory reports |
This report offers detailed analysis of the current regulatory framework in place in Thailand for cannabis and cannabinoids, including CBD and hemp. It covers everything from cultivation and processing to finished products, extracts and import/export
US cannabis industry has ‘lost its shine’, but easing taxes may re-attract investors
2nd October 2023 - News analysis |
Stakeholders are feeling more optimistic that relief could be on its way for the US cannabis industry, which is currently struggling
Bill regulating hemp and kratom products passes the House…
26th September 2023 - Alerts | North America, North Carolina, United States |
Canada: CBD and cannabis regulation, September 2023
22nd September 2023 - Regulatory reports |
This report provides detailed analysis of the regulatory framework in place in Canada for CBD and other cannabinoids, hemp, and cannabis (both recreational and medical)
Slovakia: CBD and cannabis regulation, September 2023
20th September 2023 - Regulatory reports |
This report provides a detailed analysis of the current regulatory framework in place for hemp, CBD and cannabis in Slovakia, covering all policy areas
Injunction prevents enforcement of law prohibiting IHDC sales…
12th September 2023 - Alerts | Arkansas, North America, United States |
Struggling industry blames FDA as Canadian companies leave US market
7th September 2023 - News analysis |
Another major Canadian cannabinoid company is leaving the US market amid concerns over the regulatory environment some say the US Food and Drug Administration has caused